Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Acquisitions (2016 - 2020)

Historic Acquisitions for Aytu Biopharma (AYTU) over the last 4 years, with Q2 2020 value amounting to $5.5 million.

  • Aytu Biopharma's Acquisitions changed N/A to $5.5 million in Q2 2020 from the same period last year, while for Jun 2021 it was $72393.0, marking a year-over-year increase of 11548.16%. This contributed to the annual value of $15.7 million for FY2021, which is 16875.21% up from last year.
  • As of Q2 2020, Aytu Biopharma's Acquisitions stood at $5.5 million.
  • Aytu Biopharma's 5-year Acquisitions high stood at $5.5 million for Q2 2020, and its period low was -$5.4 million during Q2 2017.
  • Its 3-year average for Acquisitions is -$155869.0, with a median of -$540000.0 in 2016.